C. Rees

1.4k total citations
7 papers, 151 citations indexed

About

C. Rees is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, C. Rees has authored 7 papers receiving a total of 151 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Molecular Biology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in C. Rees's work include Cancer therapeutics and mechanisms (2 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers) and Gastric Cancer Management and Outcomes (2 papers). C. Rees is often cited by papers focused on Cancer therapeutics and mechanisms (2 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers) and Gastric Cancer Management and Outcomes (2 papers). C. Rees collaborates with scholars based in United Kingdom, Taiwan and France. C. Rees's co-authors include Aimery de Gramont, Yee Chao, Liqun Chen, Yoon‐Koo Kang, Milan Kujundžić, Francisco Javier Ramos, Amitesh Roy, Ho Yeong Lim, David Cunningham and Josep Tabernero and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

C. Rees

6 papers receiving 151 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Rees United Kingdom 4 90 60 43 34 34 7 151
Alvydas Česas Lithuania 7 88 1.0× 82 1.4× 26 0.6× 17 0.5× 18 0.5× 14 161
Jimin Min United States 9 74 0.8× 97 1.6× 52 1.2× 84 2.5× 12 0.4× 15 228
Matthew S. Strand United States 5 73 0.8× 68 1.1× 39 0.9× 31 0.9× 4 0.1× 11 166
Lupe Sanchez-Mete Italy 7 56 0.6× 50 0.8× 35 0.8× 37 1.1× 12 0.4× 13 161
Nicholas A. Ullman United States 5 135 1.5× 35 0.6× 23 0.5× 28 0.8× 7 0.2× 10 196
Ruben I. Calderon United States 5 70 0.8× 83 1.4× 15 0.3× 13 0.4× 15 0.4× 5 151
Zhenghao Lu China 7 110 1.2× 66 1.1× 89 2.1× 57 1.7× 8 0.2× 13 237
S. G. Afanasyev Russia 6 42 0.5× 53 0.9× 51 1.2× 28 0.8× 4 0.1× 46 146
Avni M. Desai United States 6 87 1.0× 29 0.5× 31 0.7× 48 1.4× 6 0.2× 12 131
Hani S. Mousa Italy 6 84 0.9× 47 0.8× 19 0.4× 60 1.8× 9 0.3× 8 215

Countries citing papers authored by C. Rees

Since Specialization
Citations

This map shows the geographic impact of C. Rees's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Rees with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Rees more than expected).

Fields of papers citing papers by C. Rees

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Rees. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Rees. The network helps show where C. Rees may publish in the future.

Co-authorship network of co-authors of C. Rees

This figure shows the co-authorship network connecting the top 25 collaborators of C. Rees. A scholar is included among the top collaborators of C. Rees based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Rees. C. Rees is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
2.
3.
Cunningham, David, Sunmin Park, Yoon‐Koo Kang, et al.. (2011). Randomized phase II study of PEP02, irinotecan, or docetaxel as a second-line therapy in gastric or gastroesophageal junction adenocarcinoma.. Journal of Clinical Oncology. 29(4_suppl). 6–6. 4 indexed citations
4.
Plummer, Ruth, C. Rees, I. Judson, et al.. (1999). Phase I trial of ZD9331 in adult patients with refractory solid malignancies administered by 30-min infusion on days 1 and 8 with the cycle repeated every 3 weeks. European Journal of Cancer. 35. S285–S285. 8 indexed citations
5.
Mitchell, F., C. Rees, I. Judson, et al.. (1998). Plasma 2 '-deoxyuridine (dUrd) as a surrogate marker of thymidylate synthase (TS) inhibition in patients in phase I clinical trials of the TS inhibitor ZD9331. Annals of Oncology. 1 indexed citations
6.
Coope, RC, C. Rees, V. Thirunavukkarasu, et al.. (1997). Presence of exon 5-deleted oestrogen receptor in human breast cancer: functional analysis and clinical significance. British Journal of Cancer. 75(8). 1173–1184. 37 indexed citations
7.
Rees, C., Daniel Sinnett, C. Lowdell, J English, & R. Charles Coombes. (1996). A Pilot study to evaluate paclitaxel (Taxol™) as primary medical treatment for patients with inoperable stage III and IV breast carcinoma. European Journal of Cancer. 32(13). 2354–2356. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alvydas Česas Breakdown of academic impact, for papers by Jimin Min Breakdown of academic impact, for papers by Matthew S. Strand Breakdown of academic impact, for papers by Lupe Sanchez-Mete Breakdown of academic impact, for papers by Nicholas A. Ullman Breakdown of academic impact, for papers by Ruben I. Calderon Breakdown of academic impact, for papers by Zhenghao Lu Breakdown of academic impact, for papers by S. G. Afanasyev Breakdown of academic impact, for papers by Avni M. Desai Breakdown of academic impact, for papers by Hani S. Mousa
Rankless by CCL
2026